Ginkgo Bioworks Holdings (DNA) Net Cash Flow (2020 - 2026)

Ginkgo Bioworks Holdings has reported Net Cash Flow for 7 years, with the latest figure at -$23.3 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow rose 90.69% year-over-year to -$23.3 million; the trailing twelve-month figure through Mar 2026 stood at -$166.5 million (up 68.69% YoY), and the FY2025 full-year result was -$393.6 million, down 2.61% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$23.3 million, down from $55.6 million in the prior quarter.
• The five-year high for Net Cash Flow was $55.6 million in Q4 2025, with the low at -$250.4 million in Q1 2025.
• Historically, Net Cash Flow has averaged -$82.6 million across 5 years, with a median of -$94.5 million in 2025.
• Annual changes were most pronounced in 2023 — Net Cash Flow tumbled 557.67% — and 2025, when it soared 199.71%.
• Ginkgo Bioworks Holdings' Net Cash Flow stood at $23.0 million in 2022, then plunged by 557.67% to -$105.1 million in 2023, then soared by 47.0% to -$55.7 million in 2024, then soared by 199.71% to $55.6 million in 2025, then sank by 141.97% to -$23.3 million in 2026.
• The last three Net Cash Flow figures came in at -$23.3 million (Q1 2026), $55.6 million (Q4 2025), and -$94.5 million (Q3 2025), per Business Quant data.